AxelaRx B.V
Netherlands
unknown
unknown
Stage
2
Investors
About
AxelaRx B.V deploys molecular imaging techniques to generate accurate data about the distribution of fluorescent labelled drugs and tracers, accelerating drug development and enhancing early critical decision making through fluorescence and in-human microdosing.
Explore AxelaRx B.V's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.